Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
FEMALE
NCT06175754

Laser Treatment of Reticular Leg Veins vs. Sclerotherapy

Led by Derzhavin Tambov State University · Updated on 2025-02-05

174

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.

CONDITIONS

Official Title

Laser Treatment of Reticular Leg Veins vs. Sclerotherapy

Who Can Participate

Age: 18Years - 75Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women over 18 years old
  • Presence of reticular veins
  • Signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Diabetes mellitus
  • Pregnancy or lactation
  • Malignant neoplasms
  • Inability or unwillingness to wear compression stockings
  • Hypersensitivity to polidocanol, cold, or sunlight
  • Bronchial asthma
  • Severe liver or kidney disease
  • Acute thrombosis or thrombophlebitis
  • Skin or soft tissue infections
  • Infectious diseases
  • Arteriosclerosis
  • Diabetic angiopathy
  • Heart defects requiring surgery
  • Fever
  • Toxic hyperthyroidism
  • Obesity
  • Tuberculosis
  • Sepsis
  • Blood composition disorders
  • Diseases requiring bed rest
  • Heart disease with decompensation
  • Known hereditary thrombophilia
  • Recent treatment for alcoholism
  • Use of oral contraceptives
  • Sedentary lifestyle

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bukina Oksana Vasilyevna

Tambov, Russia, 392002

Actively Recruiting

Loading map...

Research Team

O

Oksana V Bukina, PhD

CONTACT

G

Gusen I Kurbanov

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here